Skip to content

DR. LANGENAKEN ALEX

Active
Private limited companyfounded 2025active for 1 yearNieuwe Steenweg(H.) 28, 3870 Heers, BelgiumKBO/BCE: BE 1019.045.574
Summary

DR. LANGENAKEN ALEX has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €106,263 and a net result of €105,363. Its solvency ranks better than 48% of 20,720 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 22-01-2025 Normal situation
Activity
General medical practice NACE 86210and 1 other
Establishment unit
2.369.061.484 3870 Heers, since 22-01-2025
Financial year end
31 December
Peppol
Reachable since 24-02-2025

Board and ownership

Shareholders
  • LANGENAKEN Alex Roland Willy Ghislainact of 24-01-2025

Financial position

93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€143,548
Turnover
≈ €260,000
estimated
Profit
€105,363
Equity
€106,263
Total assets
€175,754
Score breakdownraises riskFounded in 2025Liquidity: current ratio 1.92, cash €11,449lowers riskSector: Human health activities (NACE 86)Figures for financial year 2025 (filed on 22-06-2026)Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 46% of micro companies in human health (NACE 86)
Financial strength
Strong
Solvency 85
equity 60.5% of total assets
Liquidity 40
short-term debt 39.5% · cash 6.5%
Profitability 100
return on assets 59.9%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,173 companies, NACE 86, micro)
Last 24 months 02-2026: 0.3% 03-2026: 0.3%● unchanged vs 02-2026 04-2026: 0.3%● unchanged vs 03-2026 05-2026: 0.3%● unchanged vs 04-2026 06-2026: 0.3%● unchanged vs 05-2026highest value 07-2026: 0.1%▼ -0.2 percentage points vs 06-2026lowest value 08-2026: 0.1%● unchanged vs 07-2026lowest value 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026 11-2026: 0.1%● unchanged vs 10-2026
Credit of up to €9,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity is ample, with a current ratio of 1.92, above the usual 1.5. Short-term debt is 39.5% and cash 6.5% of total assets. 39.5% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 48% of them on solvency, 10% on liquidity and 80% on profitability.

The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Founded in 2025
Companies of this age fail more often than older ones. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Figures for financial year 2025 (filed on 22-06-2026)
NBB · annual accounts
raises risk · Liquidity: current ratio 1.92, cash €11,449
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-06-2026, 39 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
39 days early
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2025.
KBO publications

Recent changes

  1. · Gazette deed IncorporationAppointment: LANGENAKEN Alex Roland Willy Ghislain (niet statutairbestuurder) · Founder: LANGENAKEN Alex Roland Willy Ghislain · Founding capital of €900, 90 shares
All 2 events

Comparable companies

These companies have the same main activity as DR. LANGENAKEN ALEX: general medical practice (NACE 86210). They are comparable in size and age: total assets between €161,000 and €192,000, founded in 2024.

CompanyTotal assetsGross margin
DR. LANGENAKEN ALEX Heers€175,754€143,548
Azilia Heart Herzele€161,412€148,343
Docteur Raimbault Ukkel€169,482€152,549
Bastiaan Baeten Huisarts Buggenhout€161,000€132,355
Dr. Céleste Wyffels Izegem€170,959€131,456
DR. MOYSONI Hamont-Achel€184,645€127,307
Dr. Femke Moens Heusden-Zolder€191,682€163,338
Full comparison

Key facts about DR. LANGENAKEN ALEX

What is the company number of DR. LANGENAKEN ALEX?
The company number of DR. LANGENAKEN ALEX is 1019.045.574. The VAT number is the same number with BE in front: BE 1019.045.574.
Where is DR. LANGENAKEN ALEX based?
The registered office is at Nieuwe Steenweg(H.) 28, 3870 Heers.Company details
What does DR. LANGENAKEN ALEX do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DR. LANGENAKEN ALEX?
The legal form of DR. LANGENAKEN ALEX is Private limited company (BV).
When was DR. LANGENAKEN ALEX founded?
DR. LANGENAKEN ALEX was founded on 22-01-2025.
Is DR. LANGENAKEN ALEX still active?
Yes, DR. LANGENAKEN ALEX is an active enterprise in the KBO register.
What is the turnover of DR. LANGENAKEN ALEX?
The turnover in financial year 2025 is ≈ €260,000. This figure is estimated from the gross margin of €143,548 and 30 comparable companies (NACE 86210). It probably lies between €210,000 and €320,000.Financials
Is DR. LANGENAKEN ALEX profitable?
In financial year 2025, DR. LANGENAKEN ALEX made a profit of €105,363.
Where can I find the annual accounts of DR. LANGENAKEN ALEX?
DR. LANGENAKEN ALEX filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.